3-52352599-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_015512.5(DNAH1):​c.2919C>T​(p.His973His) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00539 in 1,612,762 control chromosomes in the GnomAD database, including 42 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0045 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0055 ( 38 hom. )

Consequence

DNAH1
NM_015512.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -0.414

Publications

3 publications found
Variant links:
Genes affected
DNAH1 (HGNC:2940): (dynein axonemal heavy chain 1) This gene encodes an inner dynein arm heavy chain that provides structural support between the radial spokes and the outer doublet of the sperm tail. Naturally occurring mutations in this gene are associated with primary ciliary dyskinesia and multiple morphological anomalies of the flagella that result in asthenozoospermia and male infertility. Mice with a homozygous knockout of the orthologous gene are viable but have reduced sperm motility and are infertile. [provided by RefSeq, Feb 2017]
DNAH1 Gene-Disease associations (from GenCC):
  • spermatogenic failure 18
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae)
  • ciliary dyskinesia, primary, 37
    Inheritance: AR Classification: STRONG, MODERATE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), PanelApp Australia, ClinGen
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic male infertility due to sperm motility disorder
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.56).
BP6
Variant 3-52352599-C-T is Benign according to our data. Variant chr3-52352599-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 478435.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.414 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00445 (674/151398) while in subpopulation NFE AF = 0.00713 (484/67852). AF 95% confidence interval is 0.00661. There are 4 homozygotes in GnomAd4. There are 317 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
DNAH1NM_015512.5 linkc.2919C>T p.His973His synonymous_variant Exon 18 of 78 ENST00000420323.7 NP_056327.4
DNAH1XM_017006129.2 linkc.2919C>T p.His973His synonymous_variant Exon 19 of 80 XP_016861618.1
DNAH1XM_017006130.2 linkc.2919C>T p.His973His synonymous_variant Exon 19 of 79 XP_016861619.1
DNAH1XM_017006131.2 linkc.2919C>T p.His973His synonymous_variant Exon 19 of 79 XP_016861620.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
DNAH1ENST00000420323.7 linkc.2919C>T p.His973His synonymous_variant Exon 18 of 78 1 NM_015512.5 ENSP00000401514.2
DNAH1ENST00000486752.5 linkn.3180C>T non_coding_transcript_exon_variant Exon 18 of 77 2
DNAH1ENST00000497875.1 linkn.3084C>T non_coding_transcript_exon_variant Exon 19 of 21 2

Frequencies

GnomAD3 genomes
AF:
0.00446
AC:
675
AN:
151280
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000973
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.00324
Gnomad ASJ
AF:
0.00115
Gnomad EAS
AF:
0.000771
Gnomad SAS
AF:
0.00566
Gnomad FIN
AF:
0.00554
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00713
Gnomad OTH
AF:
0.00386
GnomAD2 exomes
AF:
0.00489
AC:
1218
AN:
249070
AF XY:
0.00508
show subpopulations
Gnomad AFR exome
AF:
0.000840
Gnomad AMR exome
AF:
0.00258
Gnomad ASJ exome
AF:
0.00139
Gnomad EAS exome
AF:
0.000111
Gnomad FIN exome
AF:
0.00641
Gnomad NFE exome
AF:
0.00636
Gnomad OTH exome
AF:
0.00463
GnomAD4 exome
AF:
0.00549
AC:
8021
AN:
1461364
Hom.:
38
Cov.:
32
AF XY:
0.00560
AC XY:
4068
AN XY:
726986
show subpopulations
African (AFR)
AF:
0.000627
AC:
21
AN:
33480
American (AMR)
AF:
0.00250
AC:
112
AN:
44718
Ashkenazi Jewish (ASJ)
AF:
0.00142
AC:
37
AN:
26136
East Asian (EAS)
AF:
0.000328
AC:
13
AN:
39694
South Asian (SAS)
AF:
0.00708
AC:
611
AN:
86254
European-Finnish (FIN)
AF:
0.00793
AC:
422
AN:
53184
Middle Eastern (MID)
AF:
0.00208
AC:
12
AN:
5768
European-Non Finnish (NFE)
AF:
0.00586
AC:
6515
AN:
1111762
Other (OTH)
AF:
0.00461
AC:
278
AN:
60368
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
447
894
1341
1788
2235
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
232
464
696
928
1160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00445
AC:
674
AN:
151398
Hom.:
4
Cov.:
32
AF XY:
0.00429
AC XY:
317
AN XY:
73954
show subpopulations
African (AFR)
AF:
0.000970
AC:
40
AN:
41228
American (AMR)
AF:
0.00324
AC:
49
AN:
15144
Ashkenazi Jewish (ASJ)
AF:
0.00115
AC:
4
AN:
3464
East Asian (EAS)
AF:
0.000773
AC:
4
AN:
5174
South Asian (SAS)
AF:
0.00546
AC:
26
AN:
4766
European-Finnish (FIN)
AF:
0.00554
AC:
58
AN:
10470
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00713
AC:
484
AN:
67852
Other (OTH)
AF:
0.00382
AC:
8
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.573
Heterozygous variant carriers
0
30
61
91
122
152
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00553
Hom.:
4
Bravo
AF:
0.00381
Asia WGS
AF:
0.00375
AC:
13
AN:
3478
EpiCase
AF:
0.00605
EpiControl
AF:
0.00522

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Spermatogenic failure 18;C4539798:Ciliary dyskinesia, primary, 37 Benign:1
Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:1
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

DNAH1: BP4, BP7, BS2 -

DNAH1-related disorder Benign:1
Nov 05, 2019
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.56
CADD
Benign
1.9
DANN
Benign
0.47
PhyloP100
-0.41
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs149114984; hg19: chr3-52386615; COSMIC: COSV70236615; API